Widening MedixMAB™ Cardiac marker portfolio: GDF-15


We are delighted to announce the growth of the MedixMAB antibody range with the introduction of new Growth Differentiation Factor 15 (GDF-15) products.
GDF-15 is a novel, promising cardiac marker used especially for the risk assessment of acute coronary syndrome (ACS) and chronic heart failure (CHF). Increased GDF-15 levels are associated with cardiovascular diseases and also with chronic kidney disease and cancer.

The new MedixMAB GDF-15 antibodies are produced in vitro and raised against the human protein. They offer sensitive GDF-15 detection to IVD assay development.

Please find Product Specifications, pair recommendations and more info, or request a sample: www.medixbiochemica.com